BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2019
View Archived Issues
World AIDS Day: Immediate ART initiation for neonates with HIV-1 provides significant benefits
Read More
New selective and potent mTOR inhibitor discovered through structure-based drug design
Read More
Evaluation of neuronal responses to La Crosse virus infection in human cerebral organoids
Read More
Chidamide approved in China for breast cancer indication
Read More
Takeda presents 18-month data from pivotal phase III TIDES study of TAK-003 dengue vaccine
Read More
Apatinib demonstrates safety and efficacy in phase II study in adenocarcinoma of the head and neck
Read More
Roche publishes data from iMATRIX study of atezolizumab
Read More
MiR-125b as a novel target in diabetes
Read More
Avidin describes new apoptosis inducers
Read More
Shenzhen Salubris Pharmaceuticals identifies new PAR-4 antagonists
Read More
Beijing Innocare Pharmaceutical Technology patents VEGFR inhibitors
Read More
New prostanoid EP3 receptor antagonists synthesized at Bayer
Read More
IBD Therapeutics discloses TRPM8 and TrpV1 antagonists/opioid receptor agonists
Read More
Mouse model reveals role of Rap1A in heart function
Read More
Developmental origins of pediatric brain tumors
Read More
Study links long non-coding RNAs to pulmonary hypertension
Read More
Vi-DT typhoid conjugate vaccine begins phase III study in Nepal
Read More
Pharmacodynamic responses seen with RNA interference therapy ARO-ANG3 in healthy volunteers
Read More
Aslan reports preliminary proof-of-concept data on ASLAN-004 in atopic dermatitis
Read More
Proof-of-concept study of SENS-111 in acute unilateral vestibulopathy misses primary endpoint
Read More
Concert initiates phase II study of CTP-692 as adjunctive treatment in schizophrenia
Read More
Phase IIb trial of Amphora for prevention of chlamydia and gonorrhea meets primary endpoint
Read More